CLIQ Digital announces impairment of goodwill, leading to €26.6 million loss in group expenses due to business performance deterioration and market cap decline ...

Corporation (OTC:NWPN) clarifies its lack of affiliation with Solana and any cryptocurrency ventures. Warns against ...

NFN8 Group achieves significant financial milestone by fully repaying over $11 million in obligations to NYDIG, enhancing mining capabilities and becoming debt-free in 2024. Positioned for growth in B ...

New to The Street announces strategic partnership with Brio Financial Group, combining expertise in media and financial ...

Corporation's subsidiary, Green Rain Solar, expands into Southwest for solar-powered EV charging stations. Focus on New ...

Lahontan Gold Corp. files independent Technical Report and Preliminary Economic Assessment for Santa Fe Mine project in Nevada, supporting December 11, 2024, news release ...

Cypher Metaverse Inc. closes LIFE Financing and Common Share Financing, raising $939,705.99. Michael Hopkinson appointed as CFO. Company focuses on early-stage opportunities in digital landscape ...

Vonovia shareholders approve domination and profit transfer agreement with Deutsche Wohnen at an Extraordinary General Meeting. Detailed voting results and financial calendar for 2025 available ...

ZoomAway Technologies Inc. announces Jeremy Green's resignation and Mark Romano's appointment as independent member of the Board of Directors. Company revolutionizes hospitality and travel industries ...

Sendero Resources Corp. places previously issued shares in escrow as per TSXV requirements. Shares to be released on specified dates. Company focused on copper-gold exploration in Argentina ...

Forte Group Holdings Inc. announces non-brokered private placement financing for $375,000, use of proceeds, insider participation, and regulatory considerations ...

Onco-Innovations Limited addresses recent market activity, confirming no material changes. The Canadian company focuses on cancer research and treatment with innovative therapies ...